The Clearance of Immune Complexes From the Circulation of Man and Other Primates
References (103)
Mechanisms of glomerular injury in immune-complex disease
Kidney Int
(1985)Disposition of IgA-containing circulating immune complexes
Am J Kidney Dis
(1988)- et al.
Physiological and pathological aspects of circulating immune complexes
Kidney Int
(1989) - et al.
Clearance of human antibody/DNA immune complexes and free DNA from the circulation of the nonhuman primate
Clin Immunol Immunopathol
(1987) - et al.
The erythrocyte-immune complex-glomerulonephritis connection in man
Kidney Int
(1987) - et al.
Fcspecific reticulo-endothelial clearance in systemic lupus erythematosus and glomerulonephritis
Am J Kidney Dis
(1984) - et al.
Failure to relate mononuclear phagocyte system function to HLA-A, B, C, DR, DQ antigens in membranous nephropathy
Am J Kidney Dis
(1987) - et al.
Interaction of cationized antigen with rat glomerular basement membrane: In situ immune complex formation
Kidney Int
(1982) The effects of corticosteroids on IgG Fc receptor and complement receptor-mediated interaction of monocytes with red cells
Clin Immunol Immunopathol
(1981)- et al.
Intralipid and reticuloendothelial clearance
Lancet
(1980)
Immune complexes bind preferentially to specific subpopulations of human erythrocytes
Clin Immunol Immunopathol
(1990)
Experimental immune complex-mediated glomerulonephritis in the nonhuman primate
Kidney Int
(1991)
Low capacity of erythrocytes to bind with immune complexes via C3b receptor in patients with systemic lupus erythematosus: Correlation with pathological proteinuria
Clin Immunol Immunopathol
(1985)
Abnormal expression of complement receptor (CR1) in IgA nephritis: Increase in erythrocytes and loss of glomeruli in patients with impaired renal function
Clin Immunol Immunopathol
(1986)
C3b receptor (CR1) on erythrocytes in various diseases
Immunol Lett
(1984)
Primate erythrocyte-immune complex-clearing mechanism
J Clin Invest
(1983)
Factors influencing the binding of large immune complexes to the primate erythrocyte CR1 receptor
Clin Immunol Immunopathol
(1984)
Demonstration of Cab receptor-like activity and of decay-accelerating factor-like activity on rabbit erythrocytes
Eur J Immunol
(1986)
Complement as a regulator of interactions between immune complexes and cell membranes
J Immunol
(1974)
The kinetics of clearance of human antibodyldsDNA immune complexes from rabbit circulation
Effects of dsDNA size, rheumatoid factor, and reduction and alkylation of the antibodies. J Immunol
(1986)
In vivo and in vitro studies of the binding of antibody/dsDNA immune complexes to rabbit and guinea pig platelets
J Immunol
(1985)
Activation of human platelets through gp140, the C3d/EBV receptor (CR2)
Eur J Immunol
(1987)
CR3 receptor on platelets and its role in the prostaglandin metabolic pathway
Immunol Cell Biol
(1987)
Cellular distribution of complement receptor type 4 (CR4): Expression on human platelets
J Immunol
(1987)
Molecular cloning and chromsomal localization of human membrane cofactor protein (MCP)
J Exp Med
(1988)
Platelet Fc receptor
Increased expression in myeloproliferative disease. J Clin Invest
(1981)
Complement depletion accelerates the clearance of immune complexes from the circulation of primates
J Clin Invest
(1984)
Immune complex/erythrocyte complement receptor interactions in vivo during induction of glomerulonephritis in nonhuman primates
J Lab Clin Med
(1990)
Human plateletimmune complex interaction in plasma
J Lab Clin Med
(1982)
Reduced immune adherence of antigen/antibody complexes formed in the presence of complement in vivo and in vitro
Complement Inflamm
(1989)
Report of the Task Group on Reference Man
(1975)
Blood and other body fluids
FASEB J
(1961)
National Academy of Sciences, National Research Council: Handbook of Biological Data
(1961)
Laboratory Animal Medicine. American College of Laboratory Animal Medicine Series
(1975)
Opsonic requirements for intravascular clearance after splenectomy
N Engl J Med
(1981)
Receptor specific clearance by the reticuloendothelial system in chronic liver diseases
Demonstration of defective Cab-specific clearance in primary biliary cirrhosis. J Clin Invest
(1978)
Differential binding of immunoglobulin A and immunoglobulin Gl immune complexes to primate erythrocytes in vivo
J Clin Invest
(1986)
Abnormal clearance of soluble aggregates of human immunoglobulin G in patients with systemic lupus erythematosus
Clin Exp Immunol
(1988)
The spleen as a filter
N Engl J Med
(1987)
In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees
J Clin Invest
(1989)
Modulation of the circulation and hepatic uptake of immune complexes by carbohydrate recognition systems
J Immunol
(1982)
A serial study of splenic reticuloendothelial system Fc receptor functional activity in systemic lupus erythematosus
Arthritis Rheum
(1982)
Reticuloendothelial Fc receptor function in SLE patients. I. Primary HLA linked defect or acquired dysfunction secondary to disease activity?
Clin Exp Immunol
(1984)
Dynamics of mononuclear phagocyte system Fc receptor function in systemic lupus erythematosus
Relation to disease activity and circulating immune complexes. Clin Exp Immunol
(1983)
Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus
N Engl J Med
(1979)
High-dose, pulse intravenous methylprednisolone enhances Fc-y receptormediated mononuclear phagocyte function in systemic lupus erythematosus
Arthritis Rheum
(1989)
Modification of glomerular immune complex deposition in mice by activation of the reticuloendothelial system
J Clin Invest
(1981)
Cited by (0)
Supported in part by National Institutes of Health Grants No. HL 25404 and DK 39485, and by the H. David White Renal Research Fund of the Ohio State University
Copyright © 1991 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.